Asia · Regional markets · CNBC-TV18

Dr Reddy's gets DGCI clearance for Zytorvi; Here's how company shares reacted

Published by CNBC-TV18 · India 3 h ago

Dr Reddy's Laboratories received DCGI approval for Zytorvi to treat advanced oesophageal squamous cell carcinoma in India.

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Business Standard

Hero Motors, SML Mahindra, Wheels India locked at 10% lower circuits

The Straits Times Business

OCBC customers can hold Malaysian ringgit in Singapore savings accounts from Oct 23

These are the most active investors in India’s startups

The Business Times

Temasek and GIC deny instigating Indonesian stock rout

Pulse (Maeil Business)

Hiring at Korea’s top banks drops nearly 40% in three years

China Daily Business

Paris feels impact of looting aftermath